Kyle Bass Challenges Biogen Fumaderm Patent By: Benzinga via Benzinga April 22, 2015 at 12:58 PM EDT A patent held by Biogen Inc (NASDAQ: BIIB) on its Fumaderm psoriasis treatment got challenged Tuesday by hedge fund manager and short ... Read More >> Related Stocks: Biogen Idec